カテゴリー： 世界, 医療/バイオ, LP Information

世界のトシリズマブ注射市場予測 2023年-2029年

【英語タイトル】Global Tocilizumab Injection Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC09992）・商品コード：LP23DC09992
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：75
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のトシリズマブ注射市場」は、過去の販売実績から2022年の世界のトシリズマブ注射の総販売量を検討し、2023年から2029年の予測されるトシリズマブ注射の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のトシリズマブ注射の市場規模を掲載し、XXX百万米ドル規模の世界のトシリズマブ注射市場の詳細な分析を提供します。本インサイトレポートは、世界のトシリズマブ注射業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のトシリズマブ注射市場における各社の独自のポジションをより深く理解するために、トシリズマブ注射製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のトシリズマブ注射市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。トシリズマブ注射の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。トシリズマブ注射の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。トシリズマブ注射のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

トシリズマブ注射の世界主要メーカーとしては、Roche、 Bio-Thera Solutions,Ltd.、 Livzon Pharmaceutical Group Inc.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のトシリズマブ注射市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではトシリズマブ注射市場をセグメンテーションし、種類別 (ジェネリック医薬品、先発医薬品)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ジェネリック医薬品、先発医薬品

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のトシリズマブ注射市場の10年間の市場状況・展望は？
・世界および地域別に見たトシリズマブ注射市場成長の要因は何か？
・トシリズマブ注射の市場機会はエンドマーケットの規模によってどのように変化するのか？
・トシリズマブ注射のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：トシリズマブ注射の年間販売量2018-2029、地域別現状・将来分析
・トシリズマブ注射の種類別セグメント：ジェネリック医薬品、先発医薬品
・トシリズマブ注射の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・トシリズマブ注射の用途別セグメント：病院、診療所、その他
・トシリズマブ注射の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のトシリズマブ注射市場
・企業別のグローバルトシリズマブ注射市場データ：2018-2023年の年間販売量、市場シェア
・企業別のトシリズマブ注射の年間売上：2018-2023年の売上、市場シェア
・企業別のトシリズマブ注射販売価格
・主要企業のトシリズマブ注射生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

トシリズマブ注射の地域別レビュー
・地域別のトシリズマブ注射市場規模2018-2023：年間販売量、売上
・主要国別のトシリズマブ注射市場規模2018-2023：年間販売量、売上
・南北アメリカのトシリズマブ注射販売の成長
・アジア太平洋のトシリズマブ注射販売の成長
・ヨーロッパのトシリズマブ注射販売の成長
・中東・アフリカのトシリズマブ注射販売の成長

南北アメリカ市場
・南北アメリカの国別のトシリズマブ注射販売量、売上（2018-2023）
・南北アメリカのトシリズマブ注射の種類別販売量
・南北アメリカのトシリズマブ注射の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のトシリズマブ注射販売量、売上（2018-2023）
・アジア太平洋のトシリズマブ注射の種類別販売量
・アジア太平洋のトシリズマブ注射の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のトシリズマブ注射販売量、売上（2018-2023）
・ヨーロッパのトシリズマブ注射の種類別販売量
・ヨーロッパのトシリズマブ注射の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のトシリズマブ注射販売量、売上（2018-2023）
・中東・アフリカのトシリズマブ注射の種類別販売量
・中東・アフリカのトシリズマブ注射の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・トシリズマブ注射の製造コスト構造分析
・トシリズマブ注射の製造プロセス分析
・トシリズマブ注射の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・トシリズマブ注射の主要なグローバル販売業者
・トシリズマブ注射の主要なグローバル顧客

地域別のトシリズマブ注射市場予測レビュー
・地域別のトシリズマブ注射市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・トシリズマブ注射の種類別市場規模予測
・トシリズマブ注射の用途別市場規模予測

主要企業分析
Roche、 Bio-Thera Solutions,Ltd.、 Livzon Pharmaceutical Group Inc.
・企業情報
・トシリズマブ注射製品
・トシリズマブ注射販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Tocilizumab Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Tocilizumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tocilizumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tocilizumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tocilizumab Injection players cover Roche, Bio-Thera Solutions,Ltd. and Livzon Pharmaceutical Group Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Tocilizumab Injection Industry Forecast” looks at past sales and reviews total world Tocilizumab Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Tocilizumab Injection sales for 2023 through 2029. With Tocilizumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tocilizumab Injection industry.
This Insight Report provides a comprehensive analysis of the global Tocilizumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tocilizumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tocilizumab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tocilizumab Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tocilizumab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Tocilizumab Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Generic Drugs
Original Drugs
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Roche
Bio-Thera Solutions,Ltd.
Livzon Pharmaceutical Group Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tocilizumab Injection market?
What factors are driving Tocilizumab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tocilizumab Injection market opportunities vary by end market size?
How does Tocilizumab Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tocilizumab Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tocilizumab Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tocilizumab Injection by Country/Region, 2018, 2022 & 2029
2.2 Tocilizumab Injection Segment by Type
2.2.1 Generic Drugs
2.2.2 Original Drugs
2.3 Tocilizumab Injection Sales by Type
2.3.1 Global Tocilizumab Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Tocilizumab Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tocilizumab Injection Sale Price by Type (2018-2023)
2.4 Tocilizumab Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Tocilizumab Injection Sales by Application
2.5.1 Global Tocilizumab Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Tocilizumab Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tocilizumab Injection Sale Price by Application (2018-2023)
3 Global Tocilizumab Injection by Company
3.1 Global Tocilizumab Injection Breakdown Data by Company
3.1.1 Global Tocilizumab Injection Annual Sales by Company (2018-2023)
3.1.2 Global Tocilizumab Injection Sales Market Share by Company (2018-2023)
3.2 Global Tocilizumab Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Tocilizumab Injection Revenue by Company (2018-2023)
3.2.2 Global Tocilizumab Injection Revenue Market Share by Company (2018-2023)
3.3 Global Tocilizumab Injection Sale Price by Company
3.4 Key Manufacturers Tocilizumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tocilizumab Injection Product Location Distribution
3.4.2 Players Tocilizumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tocilizumab Injection by Geographic Region
4.1 World Historic Tocilizumab Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Tocilizumab Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tocilizumab Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tocilizumab Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Tocilizumab Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tocilizumab Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tocilizumab Injection Sales Growth
4.4 APAC Tocilizumab Injection Sales Growth
4.5 Europe Tocilizumab Injection Sales Growth
4.6 Middle East & Africa Tocilizumab Injection Sales Growth
5 Americas
5.1 Americas Tocilizumab Injection Sales by Country
5.1.1 Americas Tocilizumab Injection Sales by Country (2018-2023)
5.1.2 Americas Tocilizumab Injection Revenue by Country (2018-2023)
5.2 Americas Tocilizumab Injection Sales by Type
5.3 Americas Tocilizumab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tocilizumab Injection Sales by Region
6.1.1 APAC Tocilizumab Injection Sales by Region (2018-2023)
6.1.2 APAC Tocilizumab Injection Revenue by Region (2018-2023)
6.2 APAC Tocilizumab Injection Sales by Type
6.3 APAC Tocilizumab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tocilizumab Injection by Country
7.1.1 Europe Tocilizumab Injection Sales by Country (2018-2023)
7.1.2 Europe Tocilizumab Injection Revenue by Country (2018-2023)
7.2 Europe Tocilizumab Injection Sales by Type
7.3 Europe Tocilizumab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tocilizumab Injection by Country
8.1.1 Middle East & Africa Tocilizumab Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tocilizumab Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Tocilizumab Injection Sales by Type
8.3 Middle East & Africa Tocilizumab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tocilizumab Injection
10.3 Manufacturing Process Analysis of Tocilizumab Injection
10.4 Industry Chain Structure of Tocilizumab Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tocilizumab Injection Distributors
11.3 Tocilizumab Injection Customer
12 World Forecast Review for Tocilizumab Injection by Geographic Region
12.1 Global Tocilizumab Injection Market Size Forecast by Region
12.1.1 Global Tocilizumab Injection Forecast by Region (2024-2029)
12.1.2 Global Tocilizumab Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tocilizumab Injection Forecast by Type
12.7 Global Tocilizumab Injection Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Tocilizumab Injection Product Portfolios and Specifications
13.1.3 Roche Tocilizumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Bio-Thera Solutions,Ltd.
13.2.1 Bio-Thera Solutions,Ltd. Company Information
13.2.2 Bio-Thera Solutions,Ltd. Tocilizumab Injection Product Portfolios and Specifications
13.2.3 Bio-Thera Solutions,Ltd. Tocilizumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bio-Thera Solutions,Ltd. Main Business Overview
13.2.5 Bio-Thera Solutions,Ltd. Latest Developments
13.3 Livzon Pharmaceutical Group Inc.
13.3.1 Livzon Pharmaceutical Group Inc. Company Information
13.3.2 Livzon Pharmaceutical Group Inc. Tocilizumab Injection Product Portfolios and Specifications
13.3.3 Livzon Pharmaceutical Group Inc. Tocilizumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Livzon Pharmaceutical Group Inc. Main Business Overview
13.3.5 Livzon Pharmaceutical Group Inc. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Tocilizumab Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tocilizumab Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Generic Drugs
Table 4. Major Players of Original Drugs
Table 5. Global Tocilizumab Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Tocilizumab Injection Sales Market Share by Type (2018-2023)
Table 7. Global Tocilizumab Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Tocilizumab Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Tocilizumab Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Tocilizumab Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Tocilizumab Injection Sales Market Share by Application (2018-2023)
Table 12. Global Tocilizumab Injection Revenue by Application (2018-2023)
Table 13. Global Tocilizumab Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Tocilizumab Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Tocilizumab Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Tocilizumab Injection Sales Market Share by Company (2018-2023)
Table 17. Global Tocilizumab Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Tocilizumab Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Tocilizumab Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Tocilizumab Injection Producing Area Distribution and Sales Area
Table 21. Players Tocilizumab Injection Products Offered
Table 22. Tocilizumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tocilizumab Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Tocilizumab Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Tocilizumab Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Tocilizumab Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Tocilizumab Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Tocilizumab Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Tocilizumab Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Tocilizumab Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Tocilizumab Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Tocilizumab Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Tocilizumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Tocilizumab Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Tocilizumab Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Tocilizumab Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Tocilizumab Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Tocilizumab Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Tocilizumab Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Tocilizumab Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Tocilizumab Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Tocilizumab Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Tocilizumab Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Tocilizumab Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Tocilizumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Tocilizumab Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Tocilizumab Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Tocilizumab Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Tocilizumab Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Tocilizumab Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Tocilizumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Tocilizumab Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Tocilizumab Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Tocilizumab Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Tocilizumab Injection
Table 58. Key Market Challenges & Risks of Tocilizumab Injection
Table 59. Key Industry Trends of Tocilizumab Injection
Table 60. Tocilizumab Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Tocilizumab Injection Distributors List
Table 63. Tocilizumab Injection Customer List
Table 64. Global Tocilizumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Tocilizumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Tocilizumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Tocilizumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Tocilizumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Tocilizumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Tocilizumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Tocilizumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Tocilizumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Tocilizumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Tocilizumab Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Tocilizumab Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Tocilizumab Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Tocilizumab Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Roche Basic Information, Tocilizumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Tocilizumab Injection Product Portfolios and Specifications
Table 80. Roche Tocilizumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Bio-Thera Solutions,Ltd. Basic Information, Tocilizumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Thera Solutions,Ltd. Tocilizumab Injection Product Portfolios and Specifications
Table 85. Bio-Thera Solutions,Ltd. Tocilizumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bio-Thera Solutions,Ltd. Main Business
Table 87. Bio-Thera Solutions,Ltd. Latest Developments
Table 88. Livzon Pharmaceutical Group Inc. Basic Information, Tocilizumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Livzon Pharmaceutical Group Inc. Tocilizumab Injection Product Portfolios and Specifications
Table 90. Livzon Pharmaceutical Group Inc. Tocilizumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Livzon Pharmaceutical Group Inc. Main Business
Table 92. Livzon Pharmaceutical Group Inc. Latest Developments
List of Figures
Figure 1. Picture of Tocilizumab Injection
Figure 2. Tocilizumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tocilizumab Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Tocilizumab Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tocilizumab Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Generic Drugs
Figure 10. Product Picture of Original Drugs
Figure 11. Global Tocilizumab Injection Sales Market Share by Type in 2022
Figure 12. Global Tocilizumab Injection Revenue Market Share by Type (2018-2023)
Figure 13. Tocilizumab Injection Consumed in Hospital
Figure 14. Global Tocilizumab Injection Market: Hospital (2018-2023) & (K Units)
Figure 15. Tocilizumab Injection Consumed in Clinic
Figure 16. Global Tocilizumab Injection Market: Clinic (2018-2023) & (K Units)
Figure 17. Tocilizumab Injection Consumed in Other
Figure 18. Global Tocilizumab Injection Market: Other (2018-2023) & (K Units)
Figure 19. Global Tocilizumab Injection Sales Market Share by Application (2022)
Figure 20. Global Tocilizumab Injection Revenue Market Share by Application in 2022
Figure 21. Tocilizumab Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Tocilizumab Injection Sales Market Share by Company in 2022
Figure 23. Tocilizumab Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Tocilizumab Injection Revenue Market Share by Company in 2022
Figure 25. Global Tocilizumab Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Tocilizumab Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Tocilizumab Injection Sales 2018-2023 (K Units)
Figure 28. Americas Tocilizumab Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Tocilizumab Injection Sales 2018-2023 (K Units)
Figure 30. APAC Tocilizumab Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Tocilizumab Injection Sales 2018-2023 (K Units)
Figure 32. Europe Tocilizumab Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Tocilizumab Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Tocilizumab Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Tocilizumab Injection Sales Market Share by Country in 2022
Figure 36. Americas Tocilizumab Injection Revenue Market Share by Country in 2022
Figure 37. Americas Tocilizumab Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Tocilizumab Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Tocilizumab Injection Sales Market Share by Region in 2022
Figure 44. APAC Tocilizumab Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Tocilizumab Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Tocilizumab Injection Sales Market Share by Application (2018-2023)
Figure 47. China Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Tocilizumab Injection Sales Market Share by Country in 2022
Figure 55. Europe Tocilizumab Injection Revenue Market Share by Country in 2022
Figure 56. Europe Tocilizumab Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Tocilizumab Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Tocilizumab Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Tocilizumab Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Tocilizumab Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Tocilizumab Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Tocilizumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Tocilizumab Injection in 2022
Figure 73. Manufacturing Process Analysis of Tocilizumab Injection
Figure 74. Industry Chain Structure of Tocilizumab Injection
Figure 75. Channels of Distribution
Figure 76. Global Tocilizumab Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Tocilizumab Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Tocilizumab Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Tocilizumab Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Tocilizumab Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Tocilizumab Injection Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のトシリズマブ注射市場予測 2023年-2029年] (コード：LP23DC09992)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトシリズマブ注射市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のラジウム-223注射市場予測 2023年-2029年
  • 世界のストロンチウム89塩化物注射市場予測 2023年-2029年
  • 世界の再利用可能注射ペン市場予測 2023年-2029年
  • 世界の硫酸モルヒネ注射市場予測 2023年-2029年
  • 世界のサルブタモール注射市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆